MYC and lymphoma: Interestingly, Eμ‐MYC/Vav‐BFL1 DT mice developed mainly immature (B220+ IgM−) lymphomas, with a significant proportion (64%) that additionally developed CD19−B220+CD4+ stem/progenitor cell lymphomas in the thymus.